Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06858904 · ClinicalTrials.gov registry record · NA

Rehydration With a Trace Mineral Supplement

A NA study of Dehydration (Physiology), sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06858904: Completed NA study of Dehydration (Physiology), sponsored by Arizona State University.

NCT06858904 is a NA study of Dehydration (Physiology) that has completed, run by Arizona State University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06858904, a NA study of Dehydration (Physiology), has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

It is well established that post-exercise rehydration with electrolyte solutions is more effective than plain water. However, most commercially available drinks are high in electrolytes but lack some essential trace minerals. This study aims to examine the impact of a higher-electrolyte sports drink compared with a low-electrolyte, trace-mineral-rich solution and water on the time course and extent of rehydration after exercise-induced dehydration.

Primary Outcome

Body water Retention after exercise-induced dehydration

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT ConcenTrace
  • DIETARY_SUPPLEMENT ZeroLyte

Study Locations (1)

Arizona

  • Hydration Science Lab - Phoenix

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-03-26
Est. Completion 2025-08-29
Phase NA
Arizona State University

187 total trials

What the finished NCT06858904 record still lists

NCT06858904 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Dehydration (Physiology) appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06858904 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT06858904 about?

NCT06858904 is a clinical study titled "Rehydration With a Trace Mineral Supplement". It is well established that post-exercise rehydration with electrolyte solutions is more effective than plain water. However, most commercially available drinks are high in electrolytes but lack some essential trace minerals. This study aims to examine the impact of a higher-electrolyte sports drink...

What is the current status of trial NCT06858904?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2025-03-26. Estimated completion is 2025-08-29.

What conditions does trial NCT06858904 study?

This clinical trial studies the following conditions: Dehydration (Physiology).

What interventions are being tested in trial NCT06858904?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), ConcenTrace (DIETARY_SUPPLEMENT), ZeroLyte (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06858904?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06858904 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration (Physiology)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06858904's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06858904, the US trial registry maintained by the National Library of Medicine. NCT06858904 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.